==========
References
==========

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi S a, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. The Lancet. [Online] Elsevier Ltd; 2010;375(9725): 1545–1555. Available from: 10.1016/S0140-6736(10)60206-1

2. Oliveira DBL, Durigon EL, Carvalho ACL, Leal AL, Souza TS, Thomazelli LM, Moraes CTP, Vieira SE, Al G, Stewien KE (2009) Epidemiology and genetic variability of human metapneumovírus during a 4-year-long study in Southeastern Brazil. J Med Virol 81:915–921

3. Durigon, E.L., V.F. Botosso, and D.B.L. de Oliveira, Human Respiratory Syncytial Virus: Biology, Epidemiology, and Control, in Human Virology in Latin America. 2017. p. 235-254.

4. Robinson JL, Lee BE, Bastien N, Li Y (2005) Seasonality and clinical features of human metapneumovírus infection in children in northern Alberta. J Med Virol 76:98–105

5. van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD, Fouchier RA (2003) Prevalence e clinical symptoms of human metapneumovírus infection in hospitalized patients. J Infect Dis 188:1571–1577

6. Morris JA Jr, Blount RE, Savage RE (1956) Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Med 92:544–550

7. Chanock RM, Roizman B, Myers R (1957) Recovery from infants with respiratory illness of virus related to chimpanzee coryza agent. I. isolation, properties and characterization. Am J Hyg 66:281–290

8. Chanock RM, Finberg L (1957) Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiological aspects of infection in infants and young children. Am J Hyg 66:291–300